Physician profile
Jin Jung
NPI 1649616228
$986.15
in general payments reported to CMS, 2019-2025
13 companies · $205 in 2025
The $205 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2022: $357 · 2023: $98.59 · 2024: $218 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $338.84 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Merck Sharp & Dohme LLC | $162.12 | 2023-2025 | Bridion |
| Mindray Ds USA, INC. | $94.33 | 2024 | Te X, Te7 Max |
| Medtronic, INC. | $59.67 | 2025 | Avalus, Endurant Iis |
| Edwards Lifesciences Corporation | $57.60 | 2022 | |
| Chiesi USA, INC. | $49.84 | 2019 | |
| La Jolla Pharmaceutical Company | $47.91 | 2024-2025 | Giapreza |
| Abiomed | $44.86 | 2025 | |
| Grifols USA, LLC | $38.79 | 2024 | Thrombate III |
| Medtronic Vascular, INC. | $33.26 | 2019 | |
| Daiichi Sankyo INC. | $24.28 | 2019 | |
| Teleflex LLC | $19.81 | 2024 | Arrow |
| Bayer Healthcare Pharmaceuticals INC. | $14.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.